Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1124 of 6351
-
Drug cocktail shows promise against rare bone marrow cancers
Disease control CompletedThis phase II trial studies how well ruxolitinib phosphate and azacytidine work in treating patients with myelofibrosis or myelodysplastic syndrome/myeloproliferative neoplasm. Ruxolitinib phosphate may stop the growth of cancer cells by blocking some of the enzymes needed for ce…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug combo tested against standard care in prostate cancer
Disease control CompletedThe purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700 versus ADT + bicalutamide.
Phase 3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
5-Day radiation blast shows promise for containing spread of solid tumors
Disease control CompletedThis is a prospective Phase II study.The purpose of this study is to monitor the side effects and treatment outcomes of delivering higher doses of radiation therapy to the tumour, while limiting the dose of radiation to the normal tissues. This will be done using a 5 day treatmen…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
A Super-Microscope could spot acid reflux in Kids—Without guesswork?
Diagnosis PausedThe purpose of this project is to learn more about a new and promising way to diagnose acid reflux disease using a very high-powered microscope. This special microscope provides much finer detail than typical microscopes previously used for diagnosing reflux, and may help doctors…
Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC
-
Heated chemotherapy showdown: which works better for abdominal cancer spread?
Disease control OngoingThis is the first randomized trial comparing Early post-operative intraperitoneal chemotherapy (EPIC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for appendiceal and colorectal cancer. The purpose of this study is to find out what effects, good and/or bad, EPIC and HIPE…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Proton therapy breakthrough: fewer radiation sessions could boost lung cancer survival
Disease control OngoingThe purpose of this research study is to compare the effects (good and bad) on subjects and their cancer using standard chemotherapy in combination with hypofractionated proton radiation therapy. Hypofractionation is a technique that delivers higher daily doses of radiation over …
Phase 1/2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 15:10 UTC
-
A new imaging tracer may reveal hidden nerve injuries
Diagnosis Recruiting nowTo evaluate the potential usefulness of 11C/18F-HED positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
New proton combo aims to improve esophageal cancer treatment
Disease control Recruiting nowThe goal of this phase II study is to investigate the feasibility, toxicity and efficacy of a regimen incorporating a proven systemic regimen, carboplatin /paclitaxel, with conformal proton modality, followed by definitive surgery. In most combined-modality trials to date, chemot…
Sponsor: Loma Linda University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New combo therapy may delay prostate cancer's return
Disease control OngoingThis phase II trial studies how well finite androgen ablation with or without abiraterone acetate and prednisone work in treating patients with prostate cancer that has come back. Androgen can cause the growth of prostate cancer cells. Hormone therapy, such as finite androgen abl…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug combo shows promise in preventing deadly transplant complication
Disease control CompletedThis is a phase II multi-center, randomized, double blind, placebo-controlled trial. The investigators are doing this study to see if a new drug, abatacept, can be used together with a calcineurin inhibitor (cyclosporine or tacrolimus) and methotrexate to provide better protecti…
Phase 2 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Proton beam zaps breast tumors with less damage?
Disease control Recruiting nowThe purpose of this research study is to compare the effects (good and bad) on women and their cancer using proton radiation therapy. This study is being done to see if proton radiation therapy will prove to be beneficial for women with early stage breast cancer. A clinical stud…
Phase 2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 15:14 UTC
-
Glow-in-the-Dark dye could help brain cancer surgery
Disease control CompletedGlioblastoma is the most frequent primary malignant brain tumor in adults (3,000 new cases per year) and is characterized by a poor prognosis (median survival 12 months). Treatment is based mainly on surgical excision as complete as possible followed by an additional radiochemoth…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 17:21 UTC
-
A device that lets amputees feel their prosthetic limb move
Symptom relief CompletedUpper limb amputation is a devastating injury that leaves many thousands of typically young and active individuals in the US to rely on artificial arms and hands to help restore their lost function. The investigators research is focused on helping these individuals to feel where …
Sponsor: Louis Stokes VA Medical Center • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
New hope for leukemia patients who failed standard treatments
Disease control Recruiting nowThis phase II trial studies how well ponatinib hydrochloride works as second line therapy in treating patients with chronic myeloid leukemia in chronic phase that has not responded to initial treatment (first line) with imatinib mesylate, dasatinib, or nilotinib or cannot tolerat…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can early chemo beat the clock against colon cancer?
Disease control OngoingThis study sets up the final study end point and three detailed goals as the following. The main objective of study: This trial is done to assess the safety and benefit of early adjuvant chemotherapy from 10 to 14 days after surgery compared with conventional commencement after …
Phase 3 • Sponsor: Kyungpook National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a new anesthetic protect older Patients' blood pressure during surgery?
Disease control Completedwe conducted this multicentre retrospective cohort study to evaluate the association between the choice of induction agent (ciprofol versus propofol) and the incidence of IOH in geriatric patients having non-cardiac surgery. We hypothesized that ciprofol use would be associated w…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a Night-Time brace or targeted exercises halt scoliosis curves in teens?
Disease control OngoingIdiopathic scoliosis is a three-dimensional structural deformity of the spine that occurs in children. Recent reviews on bracing and exercise treatment have provided some evidence for effect of these interventions. The purpose of this study is to compare the effectiveness of nigh…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New ECG technology aims to spot hidden heart disease before the first heart attack
Diagnosis Recruiting nowCardiovascular disease (CVD) is the leading cause of death worldwide. Most individuals with CVD show no evidence of disease for decades as the disease progresses before the first onset of symptoms, often a "sudden" heart attack, finally arises. The spatial repolarization heteroge…
Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
New drug cocktail aims to deepen remissions in myeloma patients
Disease control CompletedThis phase II trial studies how well carfilzomib, lenalidomide, and dexamethasone before and after stem cell transplant works in treating patients with newly diagnosed multiple myeloma. Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cel…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis phase II trial studies reduced-intensity conditioning before donor stem cell transplant in treating patients with high-risk hematologic malignancies. Giving low-doses of chemotherapy and total-body irradiation before a donor stem cell transplant helps stop the growth of canc…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC